Trial · NCT00682578
A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
NCT00682578, Phase 3, Completed, University of Oxford
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan. Trials, record NCT00682578. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00682578
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
- NCT number
- NCT00682578
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 1,086 participants, actual
- Lead sponsor
- University of Oxford
- Conditions
- Uncomplicated Falciparum Malaria, Vivax Malaria
- Interventions
- Dihydroartemisinin + Piperaquine (Artekin), artesunate-sulphadoxin/pyrimethamine, chloroquine
- First posted
- 2008-05-22
- Last updated
- 2018-05-09
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | PCR corrected adequate clinical and parasitological response (PCR corrected 'adequate clinical and parasitological response' or ACPR) | Day 56 | |
| Secondary | Crude or PCR uncorrected ACPR | Day 56 | |
| Secondary | Early treatment failure (failure to clear parasitaemia) | 7 days | |
| Secondary | fever clearance times | Days | |
| Secondary | parasite clearance times with no recrudescence over the observation period | days | |
| Secondary | gametocyte clearance times | weeks | |
| Secondary | Haemoglobin levels on day 14 compared to admission | day 14 | |
| Secondary | safety and tolerability (rate and severity of adverse events) | day 56 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00682578
GET https://conductscience.org/api/trials/v1/NCT00682578/registered